Vulvar Cancer
📧 Sign up to get email alerts when something new happens for Vulvar Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva [Phase 2]
Phase 2 trial update evaluating paclitaxel for vulvar cancer (locally advanced, metastatic, or recurrent) has been completed, providing resu…
-
CLINICAL_TRIALS withdrawal · 2012-06-11Clinical Trial Update: Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer [NA]
A clinical trial evaluating colposcopy and high-resolution anoscopy to screen for anal dysplasia in patients with cervical, vaginal, or vulv…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers [NA]
Clinical trial update assessing the added value of SPECT/CT imaging for gynecologic cancer patients undergoing lymphatic mapping or sentinel…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
The update reports the completion of a clinical trial evaluating diagnostic imaging of lymph nodes in gynecologic cancers. The study examine…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil [NA]
This clinical trial update reports immunogenicity and reactogenicity data for alternative dosing schedules of Gardasil, the HPV vaccine; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) [Phase 1]
Phase 1 dose-escalation study of Merck's Broad Spectrum HPV Vaccine (V502-002) completed. Results were posted in 2011 and evaluated safety a…
-
CLINICAL_TRIALS research · 2011-02-23Clinical Trial Update: A New Patient Reported Outcome Instrument to Assess Symptom Experience in Women With Vulvar Neoplasms (WOMAN-PRO)
This document reports on the development and proposed use of WOMAN-PRO, a patient-reported outcome instrument to measure symptom experience …
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Phase 2]
Phase 2 trial evaluating fondaparinux to prevent blood clots in patients undergoing surgery for gynecologic cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Magnetic Resonance Imaging Guided Gynecologic Brachytherapy [NA]
A Brigham and Women's Hospital–sponsored clinical trial evaluating magnetic resonance imaging-guided gynecologic brachytherapy for cervical,…
-
CLINICAL_TRIALS research · 2009-07-29Clinical Trial Update: Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating whether nutritional supplements can improve quality of life during first-line chemotherap…
-
CLINICAL_TRIALS research · 2008-06-30Clinical Trial Update: Questionnaire Study for Gynecological Cancer Survivors
This document describes a questionnaire study for gynecological cancer survivors, with the trial status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2007-04-18Clinical Trial Update: Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer [Phase 2]
A Phase 2 study of Velcade (bortezomib) in combination with irinotecan for advanced cervical, vulvar, or vaginal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-05-26Clinical Trial Update: Effectiveness of an Individualized Symptom Education Program (ISEP) [Phase 2]
Phase 2 trial update evaluating the effectiveness of an Individualized Symptom Education Program (ISEP) for uterine and other female reprodu…